{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:32:11Z","timestamp":1755217931454,"version":"3.43.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.labinv.2025.104117","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:14:02Z","timestamp":1740050042000},"page":"104117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Optimized Next-Generation Sequencing Method for Detecting De Novo MET Amplification in Non\u2013Small Cell Lung Cancer: Prognostic and\u00a0Therapeutic Implications"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-7430","authenticated-orcid":false,"given":"Simon","family":"Cabello-Aguilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2071-6634","authenticated-orcid":false,"given":"Julie A.","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9669-8316","authenticated-orcid":false,"given":"Sol\u00e8ne","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9516-9797","authenticated-orcid":false,"given":"Quentin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Roch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Escudi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Solassol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Mazi\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-6158","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Solassol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.labinv.2025.104117_bib1","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.labinv.2025.104117_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.labinv.2025.104117_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.labinv.2025.104117_bib4","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2018.77.7326","article-title":"Phase Ib\/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer","volume":"36","author":"Wu","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.labinv.2025.104117_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.canlet.2016.07.021","article-title":"Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment","volume":"380","author":"Shi","year":"2016","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.labinv.2025.104117_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa2002787","article-title":"Capmatinib in MET exon 14-mutated or MET-amplified non-small-cell lung cancer","volume":"383","author":"Wolf","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.labinv.2025.104117_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"Pao","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104117_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JTO.0b013e318168d9d4","article-title":"MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort","volume":"3","author":"Beau-Faller","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104117_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/1078-0432.CCR-14-0450","article-title":"MET amplification status in therapy-naive adeno- and squamous cell carcinomas of the lung","volume":"21","author":"Schildhaus","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.labinv.2025.104117_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/diagnostics13040629","article-title":"An Italian multicenter perspective harmonization trial for the assessment of MET exon 14 skipping mutations in standard reference samples","volume":"13","author":"Bironzo","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.labinv.2025.104117_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JTO.0b013e318240ca0d","article-title":"Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer","volume":"7","author":"Dziadziuszko","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.labinv.2025.104117_bib12","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00432-022-04048-4","article-title":"Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer","volume":"149","author":"Fan","year":"2023","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"9","key":"10.1016\/j.labinv.2025.104117_bib13","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtho.2019.06.009","article-title":"MET IHC is a poor screen for MET amplification or MET exon 14 mutations in lung adenocarcinomas: data from a tri-institutional cohort of the Lung Cancer Mutation Consortium","volume":"14","author":"Guo","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"19","key":"10.1016\/j.labinv.2025.104117_bib14","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.3390\/cancers13195023","article-title":"MET amplification in non-small cell lung cancer (NSCLC)-a consecutive evaluation using next-generation sequencing (NGS) in a real-world setting","volume":"13","author":"Schubart","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.labinv.2025.104117_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jtho.2021.02.010","article-title":"Crizotinib in patients with MET-amplified NSCLC","volume":"16","author":"Camidge","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104117_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/2159-8290.CD-22-0586","article-title":"Osimertinib\u00a0+ savolitinib to overcome acquired MET-mediated resistance in epidermal growth factor receptor-mutated, MET-amplified non-small cell lung cancer: TATTON","volume":"13","author":"Hartmaier","year":"2023","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.labinv.2025.104117_bib17","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2018.08.008","article-title":"c-MET overexpression as a poor predictor of MET amplifications or exon 14 mutations in lung sarcomatoid carcinomas","volume":"13","author":"Mignard","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.labinv.2025.104117_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/1878-0261.12861","article-title":"Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer","volume":"15","author":"Aguado","year":"2021","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104117_bib19","article-title":"Detection of MET gene copy number in cancer samples using the droplet digital PCR method","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.labinv.2025.104117_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jtho.2022.10.015","article-title":"MET alterations in NSCLC-current perspectives and future challenges","volume":"18","author":"Remon","year":"2023","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.labinv.2025.104117_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.omtn.2022.09.009","article-title":"ifCNV: a novel isolation-forest-based package to detect copy-number variations from various targeted NGS datasets","volume":"30","author":"Cabello-Aguilar","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"32","key":"10.1016\/j.labinv.2025.104117_bib22","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2012.47.4189","article-title":"Randomized phase II trial of onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer","volume":"31","author":"Spigel","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104117_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","article-title":"The IARC TP53 database: new online mutation analysis and recommendations to users","volume":"19","author":"Olivier","year":"2002","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.labinv.2025.104117_bib24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A\u00a0framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.labinv.2025.104117_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jtho.2016.04.033","article-title":"Identifying the appropriate FISH criteria for defining MET copy number-driven lung adenocarcinoma through oncogene overlap analysis","volume":"11","author":"Noonan","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11","key":"10.1016\/j.labinv.2025.104117_bib26","article-title":"MET amplification and efficacy of nivolumab in patients with NSCLC","volume":"2","author":"Yoshimura","year":"2021","journal-title":"JTO Clin Res Rep"},{"issue":"10","key":"10.1016\/j.labinv.2025.104117_bib27","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.2008.19.1635","article-title":"Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients","volume":"27","author":"Cappuzzo","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.labinv.2025.104117_bib28","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1158\/1078-0432.CCR-22-1321","article-title":"Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors","volume":"28","author":"Solomon","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.labinv.2025.104117_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40164-021-00245-y","article-title":"MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors","volume":"10","author":"Peng","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104117_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annonc.2020.01.013","article-title":"TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer","volume":"31","author":"Oxnard","year":"2020","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.labinv.2025.104117_bib31","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.3390\/cancers15112932","article-title":"Overview of molecular detection technologies for MET in lung cancer","volume":"15","author":"Heydt","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.labinv.2025.104117_bib32","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.18632\/oncotarget.28092","article-title":"Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization","volume":"12","author":"Schmitt","year":"2021","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.labinv.2025.104117_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.18.00177","article-title":"Clonal MET amplification as a determinant of tyrosine kinase inhibitor resistance in epidermal growth factor receptor-mutant non-small-cell lung cancer","volume":"37","author":"Lai","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.labinv.2025.104117_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/15384047.2019.1617568","article-title":"De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors","volume":"20","author":"Li","year":"2019","journal-title":"Cancer Biol Ther"},{"issue":"15_suppl","key":"10.1016\/j.labinv.2025.104117_bib35","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1200\/JCO.2020.38.15_suppl.9510","article-title":"Safety and preliminary clinical activity of the MET antibody mixture, Sym015 in advanced non-small cell lung cancer (NSCLC) patients with MET amplification\/exon 14 deletion (METAmp\/Ex14\u0394)","volume":"38","author":"Camidge","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.labinv.2025.104117_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtho.2021.01.1605","article-title":"A\u00a0phase 2 study of capmatinib in patients with MET-altered lung cancer previously treated with a MET inhibitor","volume":"16","author":"Dagogo-Jack","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104117_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1078-0432.CCR-22-2180","article-title":"Preclinical study of a biparatopic METxMET antibody-drug conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC","volume":"29","author":"Oh","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.labinv.2025.104117_bib38","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.cllc.2018.11.007","article-title":"De novo MET amplification in Chinese patients with non-small-cell lung cancer and treatment efficacy with crizotinib: a multicenter retrospective study","volume":"20","author":"Song","year":"2019","journal-title":"Clin Lung Cancer"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:19:56Z","timestamp":1754435996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0023683725000273"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104117","relation":{},"ISSN":["0023-6837"],"issn-type":[{"type":"print","value":"0023-6837"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Optimized Next-Generation Sequencing Method for Detecting De Novo MET Amplification in Non\u2013Small Cell Lung Cancer: Prognostic and\u00a0Therapeutic Implications","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104117"}}